Celcuity+Logo.jpg
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium
06 déc. 2023 08h30 HE | Celcuity Inc.
MINNEAPOLIS, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today presented data from...
Transparency Market Research
Commercial Seaweed Market to Hit USD 31.1 billion by 2031, at a CAGR 7.0% | Says Transparency Market Research, Inc.
01 déc. 2023 12h30 HE | Transparency Market Research
Wilmington, Delaware, United States, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global commercial seaweed market is estimated to flourish at a CAGR of 7.0% from 2022...
Celcuity+Logo.jpg
Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium
01 déc. 2023 11h02 HE | Celcuity Inc.
MINNEAPOLIS, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that an...
ZoomRx TV Tracking
ZoomRx Announces Launch of ZoomRx TV Tracking: The First TV Media Measurement and Optimization Platform Designed for Life Sciences
29 nov. 2023 12h33 HE | ZoomRx
CAMBRIDGE, Mass., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Global life sciences consulting firm ZoomRx is set to transform how life sciences brands monitor and evaluate TV ad campaigns with today’s launch...
MnM_logo_TM_JPG.JPG
Single Use Assemblies Market worth $5.2 billion | MarketsandMarkets.
29 nov. 2023 08h00 HE | MarketsandMarkets Research Pvt. Ltd.
Chicago, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Single Use Assemblies Market in terms of revenue was estimated to be worth $2.5 billion in 2023 and is poised to reach $5.2 billion in 2028, growing at a...
logo 600X600.png
Artificial Intelligence in Drug Discovery Market to Hit US$ 3,547.4 Million by 2030: Coherent Market Insights
24 nov. 2023 06h30 HE | CMI
Burlingame, Nov. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, The global artificial intelligence in drug discovery market was valued at US$ 1,016.1Mn in 2022 and is forecast...
Celcuity+Logo.jpg
Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference
22 nov. 2023 08h05 HE | Celcuity Inc.
MINNEAPOLIS, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its...
Dyadic Logo Current.jpg
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
20 nov. 2023 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...
PG LOGO 1200x628px.jpg
Polaris Group Initiates Rolling Submission of Biologic License Application (BLA) for ADI-PEG 20 with U.S. FDA to Treat Malignant Pleural Mesothelioma
16 nov. 2023 19h49 HE | Polaris Group
TAIPEI, Taiwan and SAN DIGEO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Polaris Group (The Company, TWSE:6550), today announced that the Company has initiated the rolling submission of its Biologic License...
Research Nester Logo.jpg
Genome Editing Market revenue to hit USD 69.6 Billion by 2036, says Research Nester
14 nov. 2023 05h30 HE | Research Nester
New York, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The global genome editing market size is slated to expand at ~21.1% CAGR between 2024 and 2036. The market is poised to garner a revenue of USD 69.6...